Title : Licochalcone A inhibits EGFR signalling and translationally suppresses survivin expression in human cancer cells.

Pub. Date : 2021 Jan

PMID : 33247550






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Licochalcone A inhibits EGFR signalling and translationally suppresses survivin expression in human cancer cells. licochalcone A epidermal growth factor receptor Homo sapiens
2 Here, we reported the natural product, licochalcone A, exhibited a profound anti-tumour efficacy through directly targeting EGFR signalling. licochalcone A epidermal growth factor receptor Homo sapiens
3 Licochalcone A inhibited in vitro cell growth, colony formation and in vivo tumour growth of either wild-type (WT) or activating mutation EGFR-expressed NSCLC cells. licochalcone A epidermal growth factor receptor Homo sapiens
4 Licochalcone A bound with L858R single-site mutation, exon 19 deletion, L858R/T790M mutation and WT EGFR ex vivo, and impaired EGFR kinase activity both in vitro and in NSCLC cells. licochalcone A epidermal growth factor receptor Homo sapiens
5 Licochalcone A bound with L858R single-site mutation, exon 19 deletion, L858R/T790M mutation and WT EGFR ex vivo, and impaired EGFR kinase activity both in vitro and in NSCLC cells. licochalcone A epidermal growth factor receptor Homo sapiens
6 Mechanistically, we found that treatment with licochalcone A translationally suppressed survivin through inhibiting EGFR downstream kinases ERK1/2 and Akt. licochalcone A epidermal growth factor receptor Homo sapiens